Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase - PubMed (original) (raw)
. 2001 Jul 20;276(29):27455-61.
doi: 10.1074/jbc.M100556200. Epub 2001 May 3.
Affiliations
- PMID: 11337495
- DOI: 10.1074/jbc.M100556200
Free article
Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase
B D Cuevas et al. J Biol Chem. 2001.
Free article
Abstract
Under resting conditions, the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI3K) serves to both stabilize and inactivate the p110 catalytic subunit. The inhibitory activity of p85 is relieved by occupancy of the NH(2)-terminal SH2 domain of p85 by phosphorylated tyrosine. Src family kinases phosphorylate tyrosine 688 in p85, a process that we have shown to be reversed by the activity of the p85-associated SH2 domain-containing phosphatase SHP1. We demonstrate that phosphorylation of the downstream PI3K target Akt is increased in cells lacking SHP1, implicating phosphorylation of p85 in the regulation of PI3K activity. Furthermore, the in vitro specific activity of PI3K associated with tyrosine- phosphorylated p85 is higher than that associated with nonphosphorylated p85. Expression of wild-type p85 inhibits PI3K enzyme activity as indicated by PI3K- dependent Akt phosphorylation. The inhibitory activity of p85 is accentuated by mutation of tyrosine 688 to alanine and reversed by mutation of tyrosine 688 to aspartic acid, changes that block and mimic tyrosine phosphorylation, respectively Strikingly, mutation of tyrosine 688 to aspartic acid completely reverses the inhibitory activity of p85 on cell viability and activation of the downstream targets Akt and NFkappaB, indicative of the physiological relevance of p85 phosphorylation. Tyrosine phosphorylation of Tyr(688) or mutation of tyrosine 688 to aspartic acid is sufficient to allow binding to the NH(2)-terminal SH2 domain of p85. Thus an intramolecular interaction between phosphorylated Tyr(688) and the NH(2)-terminal SH2 domain of p85 can relieve the inhibitory activity of p85 on p110. Taken together, the data indicate that phosphorylation of Tyr(688) in p85 leads to a novel mechanism of PI3K regulation.
Similar articles
- The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras.
Jimenez C, Hernandez C, Pimentel B, Carrera AC. Jimenez C, et al. J Biol Chem. 2002 Nov 1;277(44):41556-62. doi: 10.1074/jbc.M205893200. Epub 2002 Aug 23. J Biol Chem. 2002. PMID: 12196526 - SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity.
Cuevas B, Lu Y, Watt S, Kumar R, Zhang J, Siminovitch KA, Mills GB. Cuevas B, et al. J Biol Chem. 1999 Sep 24;274(39):27583-9. doi: 10.1074/jbc.274.39.27583. J Biol Chem. 1999. PMID: 10488096 - The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
Wu CJ, O'Rourke DM, Feng GS, Johnson GR, Wang Q, Greene MI. Wu CJ, et al. Oncogene. 2001 Sep 20;20(42):6018-25. doi: 10.1038/sj.onc.1204699. Oncogene. 2001. PMID: 11593409 - Synergistic activation of a family of phosphoinositide 3-kinase via G-protein coupled and tyrosine kinase-related receptors.
Katada T, Kurosu H, Okada T, Suzuki T, Tsujimoto N, Takasuga S, Kontani K, Hazeki O, Ui M. Katada T, et al. Chem Phys Lipids. 1999 Apr;98(1-2):79-86. doi: 10.1016/s0009-3084(99)00020-1. Chem Phys Lipids. 1999. PMID: 10358930 Review. - Class IA PI3K regulatory subunits: p110-independent roles and structures.
Fox M, Mott HR, Owen D. Fox M, et al. Biochem Soc Trans. 2020 Aug 28;48(4):1397-1417. doi: 10.1042/BST20190845. Biochem Soc Trans. 2020. PMID: 32677674 Free PMC article. Review.
Cited by
- TNFR1 signaling is positively regulated by Jak-2 and c-Src via tyrosine phosphorylation.
Hapil Zevkliler FZ, Çopuroğlu FE, Ertosun MG, Mert U, Özeş D, Özeş ON. Hapil Zevkliler FZ, et al. Turk J Biol. 2023 Nov 6;48(1):1-12. doi: 10.55730/1300-0152.2677. eCollection 2024. Turk J Biol. 2023. PMID: 38665776 Free PMC article. - cGAS suppresses hepatocellular carcinoma independent of its cGAMP synthase activity.
Ma D, Yang M, Sun C, Cui X, Xiong G, Wang Q, Jing W, Chen H, Lv X, Liu S, Li T, Zhao Y, Han L. Ma D, et al. Cell Death Differ. 2024 Jun;31(6):722-737. doi: 10.1038/s41418-024-01291-9. Epub 2024 Apr 9. Cell Death Differ. 2024. PMID: 38594443 - RNA Expression of MMP12 Is Strongly Associated with Inflammatory Bowel Disease and Is Regulated by Metabolic Pathways in RAW 264.7 Macrophages.
Arosa L, Camba-Gómez M, Lorenzo-Martín LF, Clavaín L, López M, Conde-Aranda J. Arosa L, et al. Int J Mol Sci. 2024 Mar 9;25(6):3167. doi: 10.3390/ijms25063167. Int J Mol Sci. 2024. PMID: 38542140 Free PMC article. - Structural and Dynamic Analyses of Pathogenic Variants in PIK3R1 Reveal a Shared Mechanism Associated among Cancer, Undergrowth, and Overgrowth Syndromes.
Dsouza NR, Cottrell CE, Davies OMT, Tollefson MM, Frieden IJ, Basel D, Urrutia R, Drolet BA, Zimmermann MT. Dsouza NR, et al. Life (Basel). 2024 Feb 23;14(3):297. doi: 10.3390/life14030297. Life (Basel). 2024. PMID: 38541623 Free PMC article. - Divergent roles of the regulatory subunits of class IA PI3K.
Kim CW, Lee JM, Park SW. Kim CW, et al. Front Endocrinol (Lausanne). 2024 Jan 22;14:1152579. doi: 10.3389/fendo.2023.1152579. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38317714 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous